Crypt density and recruited enhancers underlie intestinal tumour initiation
Nature · 03.04.2025 · 640 (8057) · 231-239
DOI: 10.1038/s41586-024-08573-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature, online erschienen am 08.01.2025. Verfasst von Liam Gaynor und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. Hauptthemen laut MEDLINE: Enhancer Elements, Genetic, Adenoma, Carcinogenesis, Intestinal Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Oncogenic mutations that drive colorectal cancer can be present in healthy intestines for long periods without overt consequence1,2. Mutation of Apc, the most common initiating event in conventional adenomas3, activates Wnt signalling, thus conferring fitness on mutant intestinal stem cells (ISCs)4,5. Apc mutations may occur in ISCs that arise by routine self-renewal or by dedifferentiation of their progeny. Although ISCs of these different origins are fundamentally similar6,7, it is unclear whether both generate tumours equally well in uninjured intestines. It is also unknown whether cis-regulatory elements are substantively modulated upon Wnt hyperactivation or as a feature of subsequent tumours. Here we show in two mouse models that adenomas are not an obligatory outcome of Apc deletion in either ISC source, but require proximity of mutant intestinal crypts. Reduced crypt density abrogates, and aggregation of mutant colonic crypts augments, adenoma formation. Moreover, adenoma-resident ISCs open chromatin at thousands of enhancers that are inaccessible in Apc-null ISCs that are not associated with adenomas. These cis elements explain adenoma-selective gene activity and persist, with little further expansion of the repertoire, as other oncogenic mutations accumulate. Thus, cooperativity between neighbouring mutant crypts and new accessibility at specific enhancers are key steps early in intestinal tumorigenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
- Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, MA, USA.
- Department of Medicine, Harvard Medical School, Boston, MA, USA.
- Department of Molecular Oncology, Genentech, South San Francisco, CA, USA.
- Department of Biochemistry and Cellular Biology, National Center of Neurology and Psychiatry, Tokyo, Japan.
- Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. ramesh_shivdasani@dfci.harvard.edu.
ORCID-Profile: Shariq Madha, Swarnabh Bhattacharya, Mikio Hoshino, Ramesh A Shivdasani
Förderung
- NIDDK NIH HHS
Zitieren
APA
Gaynor, L., Singh, H., Tie, G., Badarinath, K., Madha, S., Mancini, A., Bhattacharya, S., Hoshino, M., de Sauvage, F. J., Murata, K., Jadhav, U., & Shivdasani, R. A. (2025). Crypt density and recruited enhancers underlie intestinal tumour initiation. Nature, 640(8057), 231-239. https://doi.org/10.1038/s41586-024-08573-9
Vancouver
Gaynor L, Singh H, Tie G, Badarinath K, Madha S, Mancini A, et al. Crypt density and recruited enhancers underlie intestinal tumour initiation. Nature. 2025;640(8057):231-239. doi:10.1038/s41586-024-08573-9
BibTeX
@article{Gaynor2025,
author = {Gaynor, Liam and Singh, Harshabad and Tie, Guodong and Badarinath, Krithika and Madha, Shariq and Mancini, Andrew and Bhattacharya, Swarnabh and Hoshino, Mikio and de Sauvage, Frederic J and Murata, Kazutaka and Jadhav, Unmesh and Shivdasani, Ramesh A},
title = {Crypt density and recruited enhancers underlie intestinal tumour initiation},
journal = {Nature},
year = {2025},
volume = {640},
number = {8057},
pages = {231--239},
doi = {10.1038/s41586-024-08573-9}
}
EUVIMED